LSV Asset Management Purchases 156,400 Shares of Pediatrix Medical Group, Inc. $MD

LSV Asset Management grew its position in Pediatrix Medical Group, Inc. (NYSE:MD) by 51.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 462,200 shares of the company’s stock after acquiring an additional 156,400 shares during the quarter. LSV Asset Management’s holdings in Pediatrix Medical Group were worth $9,886,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of MD. Global Retirement Partners LLC lifted its position in shares of Pediatrix Medical Group by 68,250.0% in the 4th quarter. Global Retirement Partners LLC now owns 1,367 shares of the company’s stock worth $29,000 after acquiring an additional 1,365 shares during the period. Blue Trust Inc. bought a new stake in shares of Pediatrix Medical Group in the 4th quarter worth approximately $37,000. TD Private Client Wealth LLC bought a new stake in shares of Pediatrix Medical Group in the 4th quarter worth approximately $39,000. KBC Group NV bought a new stake in shares of Pediatrix Medical Group in the 4th quarter worth approximately $65,000. Finally, Canada Pension Plan Investment Board bought a new stake in shares of Pediatrix Medical Group in the 2nd quarter worth approximately $83,000. Institutional investors own 97.71% of the company’s stock.

Insiders Place Their Bets

In related news, Director Shirley A. Weis sold 36,028 shares of the firm’s stock in a transaction on Wednesday, May 13th. The stock was sold at an average price of $23.75, for a total transaction of $855,665.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 1.80% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

MD has been the subject of several analyst reports. Truist Financial raised their target price on Pediatrix Medical Group from $21.00 to $23.00 and gave the stock a “hold” rating in a research report on Monday, April 13th. UBS Group raised their target price on Pediatrix Medical Group from $22.00 to $25.00 and gave the stock a “neutral” rating in a research report on Tuesday, May 12th. Deutsche Bank Aktiengesellschaft set a $19.00 target price on Pediatrix Medical Group in a research report on Friday, February 20th. Jefferies Financial Group restated a “buy” rating and set a $27.00 target price on shares of Pediatrix Medical Group in a research report on Monday, April 20th. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of Pediatrix Medical Group in a research report on Friday, March 27th. One research analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Pediatrix Medical Group currently has a consensus rating of “Hold” and an average price target of $22.50.

Pediatrix Medical Group Price Performance

Pediatrix Medical Group stock opened at $21.31 on Tuesday. The business has a 50 day simple moving average of $21.83 and a 200 day simple moving average of $21.73. Pediatrix Medical Group, Inc. has a one year low of $11.84 and a one year high of $24.99. The company has a market capitalization of $1.75 billion, a PE ratio of 10.34 and a beta of 0.70. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.33 and a quick ratio of 1.33.

Pediatrix Medical Group (NYSE:MD) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.44 earnings per share for the quarter, beating analysts’ consensus estimates of $0.37 by $0.07. Pediatrix Medical Group had a return on equity of 19.94% and a net margin of 9.02%.The firm had revenue of $476.20 million during the quarter, compared to analysts’ expectations of $465.83 million. During the same period last year, the firm posted $0.33 EPS. The business’s revenue was up 3.9% on a year-over-year basis. On average, sell-side analysts forecast that Pediatrix Medical Group, Inc. will post 2.08 EPS for the current fiscal year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.